Hypertension
Debiopharm to initiate phase III trial for Sanvar in esophageal variceal bleeding
Published in Drug Week, June 30th, 2006
The U.S. Food and Drug Administration (FDA) has reviewed the protocol for this study under the Special Protocol Assessment (SPA) process. Previous phase III trials for Sanvar in this indication were conducted in Europe.
EVB is a frequent complication of late stage liver cirrhosis that affects approximately 750,000 patients per year worldwide. Survival is directly related to effective, early control of the bleeding episode, with one in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-06-30)
More Articles from Drug Week
- Bacterial Meningitis Vaccine
Genome-based vaccine discovery evaluated against meningococcal B strains - Developmental Stuttering
Indevus reports promising phase II data for pagoclone in stuttering - Drug Development
Imagenetix announces positive safety studies on anti-inflammatory compound, 1-TDC - Drug Development
Panacos details study results of maturation inhibitor candidate for HIV - Drug Development
Regeneron receives fast-track designation for the IL-1 Trap in CIAS1-associated periodic syndromes - AIDS-Associated Kaposi Sarcoma
AIDS-associated KS prognostic index predicts mortality at initial diagnosis - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
